Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 19, 2021

SELL
$85.24 - $94.15 $2.15 Million - $2.37 Million
-25,206 Closed
0 $0
Q1 2021

Apr 15, 2021

SELL
$83.5 - $98.47 $31,479 - $37,123
-377 Reduced 1.47%
25,206 $2.16 Million
Q4 2020

Feb 04, 2021

SELL
$78.07 - $94.43 $102,740 - $124,269
-1,316 Reduced 4.89%
25,583 $2.42 Million
Q3 2020

Oct 16, 2020

BUY
$82.14 - $91.0 $47,969 - $53,144
584 Added 2.22%
26,899 $2.34 Million
Q2 2020

Jul 23, 2020

SELL
$80.93 - $91.1 $505,893 - $569,466
-6,251 Reduced 19.19%
26,315 $2.3 Million
Q1 2020

Apr 28, 2020

SELL
$70.67 - $99.01 $183,035 - $256,435
-2,590 Reduced 7.37%
32,566 $2.69 Million
Q4 2019

Jan 22, 2020

SELL
$84.35 - $95.37 $263,509 - $297,935
-3,124 Reduced 8.16%
35,156 $3.33 Million
Q3 2019

Nov 07, 2019

SELL
$85.54 - $94.26 $693,045 - $763,694
-8,102 Reduced 17.47%
38,280 $3.33 Million
Q2 2019

Jul 18, 2019

BUY
$75.4 - $92.8 $26,163 - $32,201
347 Added 0.75%
46,382 $4.24 Million
Q1 2019

Apr 16, 2019

BUY
$75.32 - $86.15 $4,443 - $5,082
59 Added 0.13%
46,035 $4.43 Million
Q4 2018

Feb 12, 2019

BUY
$73.66 - $82.02 $507,812 - $565,445
6,894 Added 17.64%
45,976 $3.95 Million
Q3 2018

Nov 08, 2018

SELL
$66.94 - $77.43 $10,978 - $12,698
-164 Reduced 0.42%
39,082 $3.37 Million
Q2 2018

Jul 19, 2018

BUY
$64.91 - $73.36 $21,679 - $24,502
334 Added 0.86%
39,246 $2.97 Million
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $3.19 Million - $3.82 Million
-45,340 Reduced 53.81%
38,912 $3.15 Million
Q4 2017

Feb 12, 2018

BUY
$72.33 - $77.64 $2.08 Million - $2.24 Million
28,822 Added 52.0%
84,252 $7.07 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $4.11 Million - $4.28 Million
55,430
55,430 $4.76 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Brookmont Capital Management Portfolio

Follow Brookmont Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookmont Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookmont Capital Management with notifications on news.